Core Scientific shares see a jump — What is fueling the stock rise

Core Scientific shares see a jump — What is fueling the stock rise
Core Scientific rises 2.18% today

Core Scientific Inc. (CORZ) is trading at $16.59, having risen 2.18% on the day. The stock sits below its 20-day ($16.74) and 50-day ($17.22) simple moving averages, but remains above the 200-day SMA ($15.92), highlighting that while sellers exert short- and medium-term pressure, long-term support is intact.

CORZ price prediction
24H -4.98%
$24.41
48H -4.71%
$24.48
7D -5.1%
$24.38
1M 20.47%
$30.95
3M 32.78%
$34.11
6M 140.33%
$61.74
12M 113.55%
$54.86
Current price: $ 25.69 -1.3200 4.89%
Closed 06/10
Daily range 25.27 Arrow from to Icon 27.45
Weekly range 25.21 Arrow from to Icon 28.57
Loading...

Highlights

  • Core Scientific restated its financials after discovering demolition costs had been misclassified, prompting disclosure of material weaknesses in internal controls.
  • The accounting corrections have no impact on revenue, adjusted EBITDA, or net cash flow for the reported quarter.
  • Technicals indicate sustained short- and medium-term selling pressure, with price expected to remain between $15.78 and $17.26, and downside risk prevailing.

Material weakness flagged after earnings restatement tightens governance scrutiny

Core Scientific held its Q4 earnings call and reported that it filed amended financial statements after its auditor identified that demolition costs had been incorrectly capitalized instead of expensed. The company clarified that these corrections do not affect revenue, adjusted EBITDA, or net cash flow. However, Core Scientific will report a material weakness in internal controls for the next four quarters, presenting ongoing governance and oversight risks.

Anton Kharitonov, expert at Traders Union, sees Core Scientific under pressure in both short and medium terms with the stock trading below its 20- and 50-day moving averages. He points out the recent accounting correction and auditor's note of material weaknesses as additional fundamental concerns. The technical landscape shows indecision, with mixed signals across momentum and oscillators, and the Awesome Oscillator failing to confirm any clear direction. Market sentiment appears fragile given unresolved governance and oversight risks, while sellers still dominate intraday momentum. "Given these persistent control issues and the lack of clear technical strength, I see material downside risks for CORZ unless controls are improved and price sustains above $15.92," Kharitonov states.

Viktoras Karapetjanc, expert at Traders Union, believes Core Scientific’s long-term bullish structure remains supported above the 200-day SMA at $15.92. He notes the company’s decisive action in promptly correcting accounting errors, which underscores management’s responsiveness and protects key financial metrics. Recent price consolidation offers new opportunities for patient investors as the market absorbs the governance-related news. "I see further growth potential for CORZ if buyers reclaim the $17.22–$17.26 resistance area, and the company’s proactive stance will help restore market confidence," Karapetjanc asserts.

Parshwa Turakhiya, analyst, observes a market stuck in a tug-of-war, with momentum oscillators and volatility bands highlighting uncertain sentiment. The recent news has triggered cautious short-term trading and limited price action within defined technical boundaries. Turakhiya notes the sideways setup presents range-trading opportunities between $15.78 and $17.26 over the next sessions. "Traders should watch for a breakout from this corridor — a move outside could quickly set the next trend," Turakhiya advises.

Mixed momentum as SMA-200 supports amid oversold signals

The SMA-200 at $15.92 acts as the nearest dynamic support, while immediate resistance levels are established at the SMA-50 ($17.22) and the Ichimoku Kijun near $16.73. Momentum signals are mixed: the daily MACD points to slight weakness, the ADX indicates a lack of clear trend strength, and oscillators show divergence; both D1 RSI and CCI suggest mild selling pressure, D1 Stoch RSI is neutral, and the BBP flags persistent oversold conditions, suggesting sellers still dominate intraday momentum. The Awesome Oscillator does not confirm a clear direction. The session's price action reflects moderate volatility, with trading centered near the middle of today's $16.26 – $16.87 range and no significant momentum since the open.

Previously it was reported that Core Scientific’s stock was experiencing short- and medium-term bearish momentum despite underlying long-term support. With current price action still constrained by key moving averages and persistent internal control concerns, traders should closely monitor for a decisive move above $17.22 or below $15.92 as the next potential directional catalyst.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.